Minerals Technologies Inc. develops, produces, and markets various mineral, mineral-based, and related systems and services. The company operates through two segments, Consumer & Specialties, and Engineered Solutions segments. The Consumer & Specialties segment offers household and personal care products, such as pet litter, personal care, fabric care, edible oil and renewable fluid purification, animal health, and agricultural products under the PREMIUM CHOICE, VitaLife, Sivocat, SIVO, RAFINOL, and ENERSOL brand names; and specialty additives products, including precipitated calcium carbonate and ground calcium carbonate products that are used in the paper, paperboard, and fiber-based packaging industries, as well as automotive, construction, consumer markets, and packaging applications. The Engineered Solutions segment provides high-temperature technology products consisting of custom-blended mineral and non-mineral products for casting auto and heavy truck parts, agriculture and construction equipment, municipal, infrastructure and other industrial castings; and environmental and infrastructure products comprising geosynthetic clay lining systems, vapor intrusion mitigation products, sub surface waterproofing systems, green roofs, wastewater remediation, drinking water purification technologies, and drilling products. In addition, this segment offers gunnable monolithic refractory products and application systems; monolithic refractory materials and pre-cast refractory shapes; refractory shapes and linings; carbon composites and pyrolitic graphite under PYROID brand; and filtration and well testing services. It markets its products primarily through its direct sales force, as well as regional distributors. The company operates in the United States, Canada, Latin America, Europe, Africa, and Asia. Minerals Technologies Inc. was incorporated in 1968 and is headquartered in New York, New York.

Minerals Technologies Inc.

Immatics ( ($IMTX) ) just unveiled an announcement. Immatics N.V. held its Annual General Meeting of Shareholders on June 18, 2026 in Tübingen, whe...

Immatics Shareholders Approve All Proposals at June 18, 2026 AGM

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immatics (IMTX) and Axsome Therapeutics (AXSM) with ...

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Axsome Therapeutics (AXSM)

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Immatics, with a price target of $17.00. ...

Bank of America Securities Sticks to Their Buy Rating for Immatics (IMTX)

The latest announcement is out from RELIEF THERAPEUTICS Holding ( ($CH:MMTX) ). MindMaze Therapeutics has secured a CHF 8.0 million strategic equit...

MindMaze Raises CHF 8 Million from Neuro.io, Eyes AI Partnership and Potential Tie-Up

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Immatics today and set a price target of $17.00. Stranahan covers the ...

Market Cap	$2.00B	P/E Ratio	12.43
52W High	$84.34	52W Low	$53.11
Div Yield	48.0%	Payout Ratio	8.9%
EPS Growth 3Y	-100.0%	52W Position	81.8%
Overall Score	74	Value Score	65
Quality Score	57	Technical Score	100

EPS Current Est	$6.33	EPS Next Est	$7.25
EPS Growth Est	+14.5%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MTX	$78.67	+2.26%	814.91K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MTX	$78.67	+2.3%	814.91K
3
4
5
6

MTX

MTX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Minerals Technologies Inc. Data in Excel

Get Minerals Technologies Inc. Data in Excel